Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-7.91	48.36	52.51
Graham Fair Price	15.57	26.03	22.52
PEG	-3.99	0.54	-0.56
Price/Book	0.07	2.44	2.44
Price/Cash Flow	-22.68	-130.29	-106.20
Prices/Earnings	-23.07	17.22	22.39
Price/Sales	-7.60	11.70	12.67
Price/FCF	-22.68	-130.29	-106.20
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-24.07	0.31	0.41
Operating Margin	26.68	0.25	0.20
ROA	31.30	< 0.005	< 0.005
ROE	0.03	0.04	30.08
ROIC	0.01	0.01	14.71
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	0.02	45.55
Dividends QOQ	< 0.005	-0.04	-3138.24
EBIT QOQ	-0.43	0.39	-8.24
EPS QOQ	-0.40	0.32	-19.87
FCF QOQ	-5.07	0.17	-96.61
Revenue QOQ	-0.13	0.10	-25.78
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	84.81	64.37	-24.10
Days Sales Outstanding (DSO)	59.00	53.44	-9.43
Inventory Turnover	1.06	1.40	31.75
Debt/Capitalization	0.67	0.67	-0.26
Quick Ratio	0.35	0.42	18.71
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	28.79	29.18	1.33
Cash	0.68	0.74	8.36
Capex	-2.32	-1.74	24.84
Free Cash Flow	-0.66	-0.55	17.35
Revenue	5.54	6.07	9.74
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.77	0.92	18.78
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	23.65	21.91	-7.36
Naive Interpretation	Member

06 - Financial Health · Bad

Rating